The poor interspecies conservation of the renin-angiotensin system prevents
the use of nonprimate in vivo models to test renin inhibitors. Thus the sm
all New-World monkey marmoset is used in many instances as a model. However
, large differences between the potencies of renin inhibitors as measured i
n human and marmoset plasma were observed. To understand this phenomenon, w
e cloned marmoset renin and angiotensinogen. They were highly homologous to
their human counterparts, except for a six-residue deletion in the marmose
t renin propeptide. Human and marmoset recombinant renins were found in vit
ro to display comparable activities, suggesting that the observed differenc
es in plasma apparent affinity of inhibitors could be due to different plas
ma protein binding of the inhibitors.